BioSpace News Archive

FDA

Neurocrine Wins FDA Approval for ‘Sprinkle’ Formulation of Ingrezza for Huntington’s Disease Chorea

Neurocrine Biosciences on Tuesday won the FDA’s approval for a sprinkle capsule formulation of Ingrezza, providing a more convenient route of treatment for Huntington’s disease patients with trouble swallowing.

May 1, 2024
·
2 min read
·
Tristan Manalac
Business

Pfizer Beats Q1 Forecast Despite 20% Revenue Drop, Cuts Four Pipeline Programs

Despite being hit with a 20% sales decline due to a plunge in demand for its COVID-19 products, Pfizer on Wednesday reported $14.88 billion in revenue in the first quarter of 2024, exceeding analyst expectations.

May 1, 2024
·
2 min read
·
Tristan Manalac
Drug Development

5 DMD Data Readouts to Watch in 2024

With three FDA approvals in the past 10 months, there is a lot of momentum in the Duchenne muscular dystrophy space. Here are five companies looking to keep it going.

May 1, 2024
·
5 min read
·
Heather McKenzie
Policy

FTC Targets ‘Junk’ Patents Including Novo’s Ozempic, GSK’s Trelegy Ellipta and Other Drugs

In a bid to improve competition in the industry, the U.S. Federal Trade Commission is challenging the patents of 20 different pharmaceutical products, disputing the accuracy and relevance of their patents.

May 1, 2024
·
2 min read
·
Tristan Manalac
Career Advice

15 Soft Skills You Should Consider for Your Resume

By incorporating soft skills in your resume, you showcase your ability to work well with others, which is important to employers.

May 1, 2024
·
1 min read
·
Angela Gabriel
Business

GSK Raises Full-Year Profit Guidance on Strong Q1 Vaccine Sales

GSK’s total sales increased 10% in the first quarter of 2024 compared to the same period last year, thanks in large part to demand for its shingles vaccine Shingrix and respiratory syncytial virus vaccine Arexvy.

May 1, 2024
·
2 min read
·
Tyler Patchen
Business

Atlanta’s Biotech Scene Prepares for New Heights

The Atlanta area is receiving more physical real estate options to foster its burgeoning biotech industry.

May 1, 2024
·
6 min read
·
Tyler Patchen
FDA

The IRA, BMS’ Big Cuts, First WHIM Approval

J&J and BMS’ challenges to Medicare drug price negotiations shut down in federal court less than a week after BMS announced it was laying off more than 2,000 employees.

May 1, 2024
·
1 min read
Career Advice

5 Mistakes People Make When Quitting—and What to Do Instead

It’s important to quit your job the right way so you can exit on a positive note, which could benefit you in the future.

May 1, 2024
·
4 min read
·
Angela Gabriel
Biotech Bay

ReCode Therapeutics to Participate in May Conferences

ReCode Therapeutics today announced that company management will participate in the upcoming May conferences.

May 1, 2024
·
2 min read